CVS needs more expensive drugs – Wall Street Journal



  1. CVS needs more expensive drugs Wall Street Journal
  2. CVS shares plummet by 7%, as expected, investments in Aetna CNBC have a negative impact
  3. CVS predicts a horrible 2019 year after signing an agreement between Aetna and Bloomberg for 68 billion dollars
  4. CVS beats T4 earnings forecast, but guides for lower earnings in 2019 TheStreet.com
  5. The actions that generate the most movement before marketing: CVS Health, Garmin, Gannett, Apple, etc. CNBC
  6. View full coverage on Google News

Source link